期刊
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
卷 104, 期 6, 页码 2017-2023出版社
AMER SOC TROP MED & HYGIENE
DOI: 10.4269/ajtmh.20-1280
关键词
-
资金
- Bill & Melinda Gates Foundation [OPP1148763]
- John Hopkins University Delivery of Oral Cholera Vaccine Effectively (DOVE) project
- National institute of Allergy and Infectious Disease [5R01AI123422]
Cholera is a severe diarrheal disease that affects many low-and middle-income countries. Current rapid diagnostic tests primarily target serotype O1, demonstrating high sensitivity and specificity, which could significantly improve detection and surveillance of cholera outbreaks.
Cholera is a severe acute, highly transmissible diarrheal disease which affects many low-and middle income countries. Outbreaks of cholera are confirmed using microbiological culture, and additional cases during the outbreak are generally identified based on clinical case definitions, rather than laboratory confirmation. Many low-resource areas where cholera occurs lack the capacity to perform culture in an expeditious manner. A simple, reliable, and low-cost rapid diagnostic test (RDT) would improve identification of cases allowing rapid response to outbreaks. Several commercial RDTs are available for cholera testing with two lines to detect either serotypes O1 and O139; however, issues with sensitivity and specificity have not been optimal with these bivalent tests. Here, we report an evaluation of a new commercially available cholera dipstick test which detects only serotype O1. In both laboratory and field studies in Kenya, we demonstrate high sensitivity (97.5%), specificity (100%), and positive predictive value (100%) of this new RDT targeting only serogroup O1. This is the first field evaluation for the new Crystal VC-O1 RDT; however, with these high-performance metrics, this RDT could significantly improve cholera outbreak detection and improve surveillance for better understanding of cholera disease burden.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据